PackGene Biotech
Signal active
Organization
Contact Information
Overview
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions.
About
Industries
Biotechnology, Health Care
Founded
2014
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
PackGene Biotech headquartered in United States, North America, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $678.7M in funding across 48 round(s). With a team of 251-500 employees, PackGene Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - PackGene Biotech, raised $14.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
1
Lead Investors
0
Total Funding Amount
$14.1M
Details
6
PackGene Biotech has raised a total of $14.1M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Late Stage Venture | |||
| 2020 | Early Stage Venture | |||
| 2019 | Seed | |||
| 2023 | Late Stage Venture | 14.1M |
Investors
PackGene Biotech is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| PackGene Biotech | - | FUNDING ROUND - PackGene Biotech | undefined |
| Kaitai Capital | - | FUNDING ROUND - Kaitai Capital | undefined |
| PackGene Biotech | - | FUNDING ROUND - PackGene Biotech | 14.1M |
| CMG-SDIC Capital Management | - | FUNDING ROUND - CMG-SDIC Capital Management | 14.1M |
Recent Activity
There is no recent news or activity for this profile.